https://www.live-feeds.com/feed/cms-makes-it-official-codifying-medicare-drug-price-negotiations-established-under-iraContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/cms-makes-it-official-codifying-medicare-drug-price-negotiations-established-under-irahttps://www.live-feeds.com/feed/cms-makes-it-official-codifying-medicare-drug-price-negotiations-established-under-ira#u194577Wed, 11 Nov 2026 17:47:05 +0000The Centers for Medicare and Medicaid Services issued a final rule on November 5, 2026, codifying the Medicare Drug Price Negotiation Program established under the Inflation Reduction Act. The regulation establishes a permanent framework for Initial Price Applicability Year 2029 and subsequent years, detailing drug selection processes, manufacturer requirements, Part D coverage, and biotech protections. The rule locks in permanent procedures for choosing high-spending drugs, negotiating maximum fair prices, guarding against product reformulation strategies, and publishing maximum fair prices.